FOS and uterine cancer: For example, we identified a lung cancer-specific transcript in the oncogene RAF1 with a deletion of the Raf-like Ras-binding domain, an uterus cancer-specific transcript in oncogene FOS (Figure 2a), and a retinoblastoma-specific transcript in the tumor suppressor GLTSCR2, and a skin-cancer-specific transcript in the tumor suppressor EMP3 (Figure 2b).